| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999409 | Urologic Oncology: Seminars and Original Investigations | 2016 | 9 Pages |
Abstract
UTX is a prognostic biomarker for patients with ccRCC both in OS and DFS prediction, especially significant in low-risk patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jiajun M.D., Li M.D., Wei M.D., Qilai M.D., Yiwei M.D., Qi M.D., Yu M.D., Jiejie Ph.D., Jianming M.D.,